The Pakistan Pharmaceutical Manufacturers Association (PPMA) is proud to announce a significant milestone in industry diversification. An IPO of Rs 1–2 Billion has been approved for a specialized Veterinary Subsidiary, dedicated to expanding veterinary pharmaceutical manufacturing.
This move marks a strategic shift toward internal growth and investment, ensuring that Pakistan’s pharma sector remains a versatile and driving force in the national economy.
